RecruitingNot ApplicableNCT07100561

30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital

Extensive Post-discharge Counselling and Phone-based Follow-up Intervention to Reduce Heart Failure Readmission- A Pilot Randomized Control Trial


Sponsor

Komfo Anokye Teaching Hospital

Enrollment

150 participants

Start Date

Jul 14, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on patients admitted to hospital with heart failure in Ghana to understand why some patients are readmitted within 30 or 90 days of discharge. The goal is to identify risk factors and improve care for people with heart failure in this region. **You may be eligible if...** - You are 18 or older - You have been diagnosed with heart failure - Your heart failure symptoms are moderate to severe (NYHA Class II, III, or IV) - You have given informed consent to participate **You may NOT be eligible if...** - Your heart failure is classified as NYHA Class I (mildest form, no symptoms during normal activity) - You do not have access to a mobile phone Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERExtensive post discharge counselling and phone-based follow up

Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.


Locations(1)

Komfo Anokye Teaching Hospital

Kumasi, Ashanti Region, Ghana

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07100561


Related Trials